John Thottathil
Director Técnico/Científico/I+D en New River Pharmaceuticals, Inc. .
Perfil
John K.
Thottathil is a professional who has worked as a Chief Scientific Officer at New River Pharmaceuticals, Inc. since 2006.
Prior to this, he worked as a Director-Core Research & Development Chemistry at Abbott Laboratories and as a Director-Outsourcing, Worldwide Process R & D at Bristol-Myers Squibb World Wide Medicines Group.
He holds a doctorate degree from the Indian Institute of Science.
Cargos activos de John Thottathil
Empresas | Cargo | Inicio |
---|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Director Técnico/Científico/I+D | 13/04/2011 |
Antiguos cargos conocidos de John Thottathil.
Empresas | Cargo | Fin |
---|---|---|
Bristol-Myers Squibb World Wide Medicines Group
Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The company is based in Lawrenceville, NJ. | Corporate Officer/Principal | - |
ABBOTT LABORATORIES | Director Técnico/Científico/I+D | - |
Formación de John Thottathil.
Indian Institute of Science | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Empresas privadas | 2 |
---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
Bristol-Myers Squibb World Wide Medicines Group
Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The company is based in Lawrenceville, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- John Thottathil